Ming Song
Chairman at Nanjing Chang'ao Pharmaceutical Co., Ltd.
Profile
Ming Song is currently the Chairman at Nanjing Chang'ao Pharmaceutical Co., Ltd.
Prior to this, he worked as an Executive Director at C&O Pharmaceutical Technology (Holdings) Ltd.
from 2005 to 2011.
Mr. Song received his graduate degree from Nanjing University in 1989 and his undergraduate degree from Sichuan University in 1982.
Ming Song active positions
Companies | Position | Start |
---|---|---|
Nanjing Chang'ao Pharmaceutical Co., Ltd. | Chairman | 2011-09-27 |
Former positions of Ming Song
Companies | Position | End |
---|---|---|
C&O Pharmaceutical Technology (Holdings) Ltd.
C&O Pharmaceutical Technology (Holdings) Ltd. Pharmaceuticals: MajorHealth Technology C&O Pharmaceutical Technology (Holdings) Ltd. manufactures and distributes pharmaceutical products. It offers anti-infection and gastrointestinal drugs, drugs for ageing adults, and specialized drugs. The firm's products are used for various indications, such as skin soft tissues infections, analgesic and antipyretic, indigestion or gastro esophageal reflux disorder, respiratory tract infections, sinusitis, hypertension and migraine. The company was founded by Lai Chi Ma and Bin Gao in 2003 and is headquartered in Hong Kong. | Director/Board Member | 2011-10-11 |
Training of Ming Song
Nanjing University | Graduate Degree |
Sichuan University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
C&O Pharmaceutical Technology (Holdings) Ltd.
C&O Pharmaceutical Technology (Holdings) Ltd. Pharmaceuticals: MajorHealth Technology C&O Pharmaceutical Technology (Holdings) Ltd. manufactures and distributes pharmaceutical products. It offers anti-infection and gastrointestinal drugs, drugs for ageing adults, and specialized drugs. The firm's products are used for various indications, such as skin soft tissues infections, analgesic and antipyretic, indigestion or gastro esophageal reflux disorder, respiratory tract infections, sinusitis, hypertension and migraine. The company was founded by Lai Chi Ma and Bin Gao in 2003 and is headquartered in Hong Kong. | Health Technology |
Nanjing Chang'ao Pharmaceutical Co., Ltd. |
- Stock Market
- Insiders
- Ming Song